Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016

PHILADELPHA-– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, will exhibit its expanded offering of new assays, instruments and software at the 2016 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo being held July 31 – August 4 at thePennsylvania Convention Center. Designed specifically for customers working in research and clinical settings, these innovative new products will be on display in booths #2334 and #2145.

“Today’s healthcare and clinical service providers are on the front line of a rapidly changing diagnostic landscape,” said Marc. N Casper, president and chief executive officer of Thermo Fisher Scientific. “Our commitment to innovation in specialty diagnostics enables these customers to meet the growing demand for more rapid, sensitive and cost-effective tests that lead to better outcomes for patients.”

The impact of opioid abuse on communities places an increasing burden on the healthcare system as well as the l

< | >